Clinical Trials
3 trialsNCT03993288 2021-07-12
Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum LekĀ® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFERĀ® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.
Sandoz
Phase 3 Completed
NCT01553123 2013-02-07
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Watson Pharmaceuticals
Phase 3 Withdrawn
NCT00199277 2005-09-20
Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
J. Uriach and Company
Phase 4 Unknown